Blogs

Ensuring sterility in medical device packaging is essential to patient safety and product efficacy. Sterility prevents contamination that could compromise device performance or patient health. As packaging technologies advance and regulatory requirements grow stricter, ensuring seal integrity has become a critical focus for manufacturers.

Medical device packaging has evolved significantly to meet the demands of modern healthcare. The growing reliance on single-use devices has heightened the need for robust and sterile packaging solutions. At the same time, sustainability has emerged as a key consideration, prompting the adoption of eco-friendly materials that require precise packaging techniques. Regulatory bodies like International Organisation for Standardisation (ISO) and Food and Drug Administration (FDA) are placing increased emphasis on packaging performance, particularly in seal integrity, to ensure compliance with global standards. Additionally, innovations in packaging materials, such as flexible films and high-barrier layers, enhance device protection but also necessitate advanced package integrity testing methods to verify their effectiveness.

The Importance of Seal Integrity in Medical Device Packaging

Seal integrity is the foundation of medical device packaging, ensuring sterility is preserved throughout the product's shelf life and until its use. A reliable seal acts as a protective barrier against contaminants such as bacteria, dust, and moisture. Any compromise in the seal can lead to sterility failures, posing serious risks to patient health. Regulatory compliance underscores the importance of robust seal integrity testing, as manufacturers must demonstrate the reliability of their packaging processes to meet global standards. Seal integrity also directly impacts product longevity, ensuring the device remains safe and effective over time. Ultimately, maintaining seal quality is crucial to uphold patient safety, as a breach in packaging could result in infections or device malfunctions.

Seal Integrity Testing of Medical Device Packaging Using Airborne Ultrasound Technology

Airborne Ultrasound technology provides a precise and non-invasive method for evaluating the seal quality of pouches and flexible packaging. This advanced seal integrity test is compatible with a wide range of packaging materials, including Tyvek®, paper, foil, film, aluminum, plastic, and poly. As a non-destructive testing technique, it ensures the package remains intact while delivering accurate and reliable results. Economical and highly efficient, Airborne Ultrasound is an ideal solution for assessing the seal integrity of finished pouches, making it both cost-effective and practical for various applications. Recognized as a standard by the FDA, it was granted the ASTM Test Method F3004–13 designation in 2013 for seal quality testing.

Airborne Ultrasound technology operates by propagating ultrasonic waves through the seal area of the package as it passes over a sensor head. These waves interact with the materials, reflecting sound signals. When the seal is free of defects, the ultrasonic waves are transmitted efficiently. However, in the presence of a defect, signal strength is significantly reduced or completely eliminated, enabling precise defect detection. The level of sound reflection and transmission is influenced by the acoustic difference between the materials within the seal. The greater the acoustic contrast, the more sound is reflected, allowing for detailed analysis of the seal’s integrity.

Seal integrity testing using Airborne Ultrasound Technology represents a leap forward in ensuring the safety and reliability of medical device packaging. By adopting this advanced, non-destructive testing method, manufacturers can meet stringent regulatory requirements, ensure product longevity, and protect patient safety. In a rapidly evolving healthcare landscape, integrating technologies like Airborne Ultrasound into packaging processes is essential for maintaining high standards and delivering trustworthy medical devices.

Since the number of complex medical devices is rising, including implantable sensors, infusion pumps, and diagnostic instruments, package integrity becomes more important. Most of these need to be handled with utmost care in order not to get contaminated, especially if they are sensitive to moisture and oxygen. Package integrity testing would, therefore, be an optimal way for determining whether the packaging would retain a sterile barrier or not.

Challenges in Medical Device Packaging

Packaging medical devices also incurs numerous environmental challenges. Moisture-sensitive equipment presents the likelihood of being exposed to wet conditions, increasing the susceptibility to compromised product integrity and subsequent health risks. Some of the key issues are as follows:

• Environmental Exposure: Moisture, dust, and other contaminants can degrade device performance if packaging fails.
• Regulatory Compliance: Strict regulations require rigorous testing to ensure packages are sealed and sterile.
• Non-Destructive Testing Requirements: For sensitive devices, packaging tests must be non-destructive, so sample integrity remains intact.

These challenges necessitate advanced testing solutions that can provide accurate, repeatable results without harming the package.

Why is Package Integrity Testing of Medical Device Packaging Important?

Package integrity testing of medical device packaging is crucial because it verifies the packaging’s ability to maintain a sterile barrier, safeguarding the device from contamination and environmental exposure throughout its shelf life. For moisture-sensitive devices, even a microscopic breach can allow microbial ingress or moisture, compromising device safety and efficacy. This testing process helps manufacturers meet stringent FDA and ISO standards, reduce product recalls, and uphold the highest safety standards. Ultimately, package integrity testing not only protects patients but also reinforces a company’s commitment to quality, ensuring that medical devices arrive in pristine condition, ready for safe use.

Ensuring Package Integrity with VeriPac Vacuum Decay Technology

PTI’s VeriPac container closure integrity testing (CCIT) method offers a non-destructive alternative to traditional leak testing methods such as water bath, bubble leak, or blue dye tests. VeriPac systems can be used for integrity testing of Tyvek and other porous packaging, ensuring the product meets regulatory and consumer standards for quality. Introduced in 2003 as an ASTM test method, this vacuum decay technology was initially developed for testing Tyvek-lidded trays.

The VeriPac system works by connecting its leak testers to a test chamber designed to hold the package sample. A vacuum is applied to the package within this chamber, and the level of vacuum, along with any changes in vacuum over a set test duration, is monitored using single or dual vacuum transducer technology. By tracking changes in both absolute and differential vacuum levels, the system can detect leaks or defects in the package with high accuracy.

• Non-destructive test method that ensures quantitative test results
• FDA recognized ASTM test method
• Referenced in USP 1207 guideline
• Cost-effective with rapid return on investment
• Simplifies inspection and validation process

The pharmaceutical biologics are the newest class of drugs requiring complex and sensitive handling. Obtained from living organisms, biologics like vaccines and antibodies have a high susceptibility to degradation if exposed to contaminants or environmental changes. Packaging of the drug must, therefore, be air-tight to meet safety and efficacy requirements; thus, there is a need for Container Closure Integrity testing (CCIT). Traditional testing methods are mainly destructive. In that case, biologics safety cannot be ensured. However, the industry is shifting towards non-destructive, deterministic, highly accurate and reliable techniques of testing.

Overview of Biologics Packaging

Biologics are sensitive to temperature, light, and contaminants, hence requiring specialty packaging to ensure shelf-life stability. Glass vials, prefilled syringes, and ampoules are some common formats with individual specifications to produce a sterile barrier. Because biologics are easily affected, the packaging needs to maintain a completely sealed environment.

Why CCI Testing Is Important for Biologics

Biologics have even the slightest impurities reduce the product's effectiveness and make it potentially unsafe. Here's why CCI testing is so important for biologics:

• Ensures Safety and Effectiveness: Biologics degrade very fast when exposed to air or moisture or any contaminants. Appropriate CCI testing ensures that the packaging is sealed.
• Regulatory Compliance: Regulatory agencies like FDA require accurate, numerical CCI testing of biologics' packaging. Noncompliance with these requirements may even lead to recalls and, therefore, harm the reputation of a manufacturer.
• Extended Shelf Life: Biologics are expensive to produce, so obtaining the CCI results in an extended shelf life with less waste and financial losses.
• Minimal Risk to Patient: Strong packaging ensures a patient does not receive a compromised product, therefore ensuring safety for the patient.

Techniques for Ensuring Container Closure Integrity

For biologics, non-destructive and reliable methods of testing are preferred over traditional techniques. Here’s an introduction to two advanced CCI methods widely used in the industry:

1. Helium Leak Detection

Helium Leak Detection (HLD) is a precise method for identifying tiny leaks in sealed systems, using helium as a tracer gas. Helium’s small atomic size and inert, non-flammable nature make it ideal for penetrating leaks, allowing accurate leakage rate measurements. Its benefits include lower weight, cost-effectiveness, and availability in various forms, setting it apart from alternatives like hydrogen.

The technique operates on mass spectrometry principles, where ionized helium ions are accelerated and directed through a magnetic field, ensuring only helium ions reach the detector. This ion current, converted to an electric current, is then displayed as a leak rate. Compared to traditional methods like vacuum bubble and dye tests, helium testing offers highly accurate, quantitative assessments across diverse packaging conditions and lifecycle stages.

With sensitivity levels as low as 1×10-12 l/s, helium leak testing enables unmatched detection of minute leaks, supporting comprehensive package integrity evaluations.

2. MicroCurrent HVLD Technology

It is one of the most advanced non-destructive, non-invasive Container Closure Integrity Testing (CCIT) methods-PTI's MicroCurrent HVLD technology-that produces very effective CCIT in any range of application, whether it be pre-filled syringes, vials, cartridges, ampoules, Blow-Fill-Seal containers, bottles, and pouches. This technology proves to be effective for leak detection of liquid-filled parenteral products. Applications include low-conductivity products, such as sterile WFI and large molecule protein-based products.

In this process, electrode probes scan the sealed container to detect any potential leaks. A variation in current flow helps identify container defects and pinpoint their location. Notably, MicroCurrent HVLD technology operates with approximately 50% lower voltage, exposing both the product and its environment to less than 5% of the voltage used in conventional HVLD methods. This makes it one of the most effective CCI solutions for parenteral and biologic products.

The complexity and sensitivity of biologics have driven the industry toward advanced, non-destructive CCI testing methods. MicroCurrent HVLD and Helium Leak Detection provide the precision, reliability, and non-invasive testing needed to ensure that biologics remain safe, effective, and compliant with regulatory standards. These techniques not only help biologics manufacturers meet regulatory requirements but also support the safe delivery of biologics to patients, ensuring the highest product integrity.

In the pharmaceutical, biotechnology, and medical device industries, the integrity of product packaging is critical to ensure product safety and efficacy. Container Closure Integrity (CCI) refers to the ability of a container closure system to maintain a sterile barrier against potential contaminants throughout the product's lifecycle. A failure in CCI can lead to product degradation, contamination, or sterility breaches, which can have serious health and economic consequences. To mitigate these risks, robust CCI testing methods are employed, with deterministic test methods emerging as the preferred approach due to their reliability and precision.

Container Closure Integrity is essential in preventing the ingress of microorganisms, moisture, or gases into sterile products, particularly in the pharmaceutical and medical sectors. As regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) emphasize the importance of CCI testing, manufacturers are increasingly adopting advanced methods to verify package integrity.

CCIT methods can be broadly classified into two categories: probabilistic and deterministic methods. Probabilistic methods, such as dye ingress and microbial ingress tests, are less reliable as they depend on operator technique and can be highly variable. Deterministic methods, on the other hand, are based on physics and provide more accurate, reproducible, and quantitative results.

Understanding Deterministic CCI Test Methods

Deterministic CCI test methods are designed to detect and quantify defects in packaging with a high degree of precision. These methods are non-destructive, highly sensitive, and capable of providing exact measurements for defects down to the sub-micron level. Unlike probabilistic methods, deterministic tests are not subject to operator variability and environmental conditions, making them ideal for ensuring reliable, repeatable results.

The following key principles differentiate deterministic test methods from probabilistic ones:

• Quantitative Data: Deterministic tests offer numerical data regarding the size and location of defects, which allows for better decision-making.
• Non-destructive Testing: Many deterministic methods allow testing without damaging the product or packaging.
• High Sensitivity: These methods can detect microleaks that may be missed by traditional probabilistic techniques.
• Repeatability: Consistency in results makes deterministic methods the preferred choice for regulatory compliance.

CCI Test Methods Offered by PTI

1. Vacuum Decay Technology

Vacuum decay testing is widely regarded as one of the most effective and precise vacuum-based methods for detecting leaks in packaging. This method offers quantitative measurements that are consistent, reliable, and accurate, along with clear pass/fail criteria.

PTI’s VeriPac series played a pivotal role in the development of the ASTM F2338 standard for vacuum decay leak testing. Recognized within the United States Pharmacopeia (USP) Chapter on Container Closure Integrity (CCI) and compliant with ISO 11607 guidelines, VeriPac technology utilizes absolute or differential pressure transducers to conduct non-destructive testing, enabling the identification of leaks and microscopic defects that might compromise package integrity.

2. MicroCurrent HVLD Technology

Deterministic CCI test methods, such as Vacuum Decay, Microcurrent HVLD, and Helium Leak Detection, represent the gold standard in package integrity testing. Their high sensitivity, repeatability, and quantitative nature make them indispensable tools for ensuring product safety and regulatory compliance. PTI offers a comprehensive suite of deterministic test methods, enabling manufacturers to confidently validate the integrity of their container closure systems across a wide range of applications.

As the regulatory landscape continues to evolve and product safety becomes an increasing priority, the role of deterministic methods in CCI testing will only grow in importance. By employing these advanced testing technologies, manufacturers can mitigate the risk of contamination, ensure product efficacy, and safeguard patient health.

3. Helium Leak Detection

Helium leak testing is a highly sensitive technique employed in container closure integrity testing (CCIT) to evaluate the seal integrity of closed systems by detecting micro-leaks. Leveraging helium’s small atomic radius and inert characteristics, this method uses helium as a tracer gas to identify extremely small breaches within the packaging

The testing process involves introducing helium into the container and subsequently applying a vacuum to generate a significant pressure differential. This pressure gradient causes helium, if there is any defect, to migrate from the container through potential leak paths. The escaping helium is then detected by a helium mass spectrometer, which measures the helium flow rate, commonly recorded as the leak rate, providing quantitative data on the package’s closure performance and integrity.

Deterministic CCI test methods, like Vacuum Decay and Helium Leak Detection, offer unmatched precision and reliability, ensuring product integrity and compliance. As regulatory standards rise, these advanced methods are crucial for safeguarding patient safety and product quality.